Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach Study.

Bonadonna RC, Giaccari A, Buzzetti R, Perseghin G, Cucinotta D, Avogaro A, Aimaretti G, Larosa M, Fanelli CG, Bolli GB.

Diabetes Metab Res Rev. 2020 Mar 2:e3304. doi: 10.1002/dmrr.3304. [Epub ahead of print]

PMID:
32118347
2.

Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.

Zen M, Saccon F, Gatto M, Montesso G, Larosa M, Benvenuti F, Iaccarino L, Doria A.

Rheumatology (Oxford). 2019 Oct 23. pii: kez422. doi: 10.1093/rheumatology/kez422. [Epub ahead of print]

PMID:
31642908
3.

An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases.

Reggia R, Andreoli L, Sebbar H, Canti V, Ceccarelli F, Favaro M, Hoxha A, Inversetti A, Larosa M, Ramoni V, Caporali R, Conti F, Doria A, Montecucco C, Rovere-Querini P, Ruffatti A, Valesini G, Zatti S, Fallo L, Lojacono A, Tincani A.

Rheumatol Adv Pract. 2019 Feb 22;3(1):rkz005. doi: 10.1093/rap/rkz005. eCollection 2019.

4.

Corrigendum to "Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population" [Nutr Metabol Cardiovasc Dis 29 (5) (May 2019) 496-503].

Bonadonna RC, Giaccari A, Buzzetti R, Aimaretti G, Cucinotta D, Avogaro A, Perseghin G, Larosa M, Bolli GB, Fanelli CG.

Nutr Metab Cardiovasc Dis. 2019 Aug;29(8):869-870. doi: 10.1016/j.numecd.2019.05.059. Epub 2019 Jun 27. No abstract available.

PMID:
31257093
5.

Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population.

Bonadonna RC, Giaccari A, Buzzetti R, Aimaretti G, Cucinotta D, Avogaro A, Perseghin G, Larosa M, Bolli GB, Fanelli CG.

Nutr Metab Cardiovasc Dis. 2019 May;29(5):496-503. doi: 10.1016/j.numecd.2019.01.011. Epub 2019 Feb 8. Erratum in: Nutr Metab Cardiovasc Dis. 2019 Aug;29(8):869-870.

PMID:
30952575
6.

Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus.

Larosa M, Del Ross T, Calligaro A, Favaro M, Zanatta E, Iaccarino L, Doria A.

Expert Rev Clin Immunol. 2019 Jun;15(6):617-627. doi: 10.1080/1744666X.2019.1601557. Epub 2019 Apr 19.

PMID:
30933534
7.

Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment.

Zanatta E, Polito P, Famoso G, Larosa M, De Zorzi E, Scarpieri E, Cozzi F, Doria A.

Exp Biol Med (Maywood). 2019 Feb;244(2):120-131. doi: 10.1177/1535370218824101. Epub 2019 Jan 22.

8.

IL-12 and IL-23/Th17 axis in systemic lupus erythematosus.

Larosa M, Zen M, Gatto M, Jesus D, Zanatta E, Iaccarino L, Inês L, Doria A.

Exp Biol Med (Maywood). 2019 Jan;244(1):42-51. doi: 10.1177/1535370218824547. Epub 2019 Jan 21.

9.

Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.

Jesus D, Matos A, Henriques C, Zen M, Larosa M, Iaccarino L, Da Silva JAP, Doria A, Inês LS.

Ann Rheum Dis. 2019 Mar;78(3):365-371. doi: 10.1136/annrheumdis-2018-214502. Epub 2019 Jan 9.

PMID:
30626657
10.

"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases.

Andreoli L, Lazzaroni MG, Carini C, Dall'Ara F, Nalli C, Reggia R, Rodrigues M, Benigno C, Baldissera E, Bartoloni-Bocci E, Basta F, Bellisai F, Bortoluzzi A, Campochiaro C, Cantatore FP, Caporali R, Ceribelli A, Chighizola CB, Conigliaro P, Corrado A, Cutolo M, D'Angelo S, De Stefani E, Doria A, Favaro M, Fischetti C, Foti R, Gabrielli A, Generali E, Gerli R, Gerosa M, Larosa M, Maier A, Malavolta N, Meroni M, Meroni PL, Montecucco C, Mosca M, Padovan M, Paolazzi G, Pazzola G, Peccatori S, Perricone R, Pettiti G, Picerno V, Prevete I, Ramoni V, Romeo N, Ruffatti A, Salvarani C, Sebastiani GD, Selmi C, Serale F, Sinigaglia L, Tani C, Trevisani M, Vadacca M, Valentini E, Valesini G, Visalli E, Vivaldelli E, Zuliani L, Tincani A.

Joint Bone Spine. 2019 Jul;86(4):475-481. doi: 10.1016/j.jbspin.2018.12.002. Epub 2018 Dec 21.

PMID:
30579917
11.

Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies.

Andreoli L, Gerardi MC, Fernandes M, Bortoluzzi A, Bellando-Randone S, Brucato A, Caporali R, Chighizola CB, Chimenti MS, Conigliaro P, Cutolo M, Cutro MS, D'Angelo S, Doria A, Elefante E, Fredi M, Galeazzi M, Gerosa M, Govoni M, Iuliano A, Larosa M, Lazzaroni MG, Matucci-Cerinic M, Meroni M, Meroni PL, Mosca M, Patanè M, Pazzola G, Pendolino M, Perricone R, Ramoni V, Salvarani C, Sebastiani GD, Selmi C, Spinelli FR, Valesini G, Scirè CA, Tincani A.

Autoimmun Rev. 2019 Feb;18(2):164-176. doi: 10.1016/j.autrev.2018.08.008. Epub 2018 Dec 18. Review.

PMID:
30572134
12.

Diagnostic and prognostic role of renal histopathology in rheumatic diseases.

Saccon F, Gatto M, Larosa M, Ometto F, Felicetti M, Padoan R, Zen M.

Reumatismo. 2018 Oct 3;70(3):165-177. doi: 10.4081/reumatismo.2018.1064. Review.

13.

Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Trentin F, Gatto M, Zen M, Larosa M, Nalotto L, Saccon F, Zanatta E, Iaccarino L, Doria A.

Clin Rev Allergy Immunol. 2018 Oct;55(2):237. doi: 10.1007/s12016-018-8704-1.

14.

Subcapsular renal hematoma after retrograde ureterorenoscopic lithotripsy: our experience.

Campobasso D, Grande M, Ferretti S, Moretti M, Facchini F, Larosa M, Salsi P, Granelli P, Pozzoli GL, Frattini A.

Minerva Urol Nefrol. 2018 Dec;70(6):617-623. doi: 10.23736/S0393-2249.18.03199-5. Epub 2018 Jul 23.

PMID:
30037212
15.

Therapy of scleroderma renal crisis: State of the art.

Zanatta E, Polito P, Favaro M, Larosa M, Marson P, Cozzi F, Doria A.

Autoimmun Rev. 2018 Sep;17(9):882-889. doi: 10.1016/j.autrev.2018.03.012. Epub 2018 Jul 10. Review.

PMID:
30005860
16.

Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Trentin F, Gatto M, Zen M, Larosa M, Maddalena L, Nalotto L, Saccon F, Zanatta E, Iaccarino L, Doria A.

Clin Rev Allergy Immunol. 2018 Apr;54(2):331-343. doi: 10.1007/s12016-018-8675-2. Review. Erratum in: Clin Rev Allergy Immunol. 2018 Oct;55(2):237. Maddalena L [corrected to Larosa M ].

17.

Can we manage lupus nephritis without chronic corticosteroids administration?

Lightstone L, Doria A, Wilson H, Ward FL, Larosa M, Bargman JM.

Autoimmun Rev. 2018 Jan;17(1):4-10. doi: 10.1016/j.autrev.2017.11.002. Epub 2017 Nov 3. Review.

18.

Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.

Zen M, Iaccarino L, Gatto M, Saccon F, Larosa M, Ghirardello A, Punzi L, Doria A.

Ann Rheum Dis. 2018 Jan;77(1):104-110. doi: 10.1136/annrheumdis-2017-211613. Epub 2017 Sep 26.

PMID:
28970217
19.

Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.

Iaccarino L, Andreoli L, Bocci EB, Bortoluzzi A, Ceccarelli F, Conti F, De Angelis R, De Marchi G, De Vita S, Di Matteo A, Emmi G, Emmi L, Gatto M, Gerli R, Gerosa M, Govoni M, Larosa M, Meroni PL, Mosca M, Pazzola G, Reggia R, Saccon F, Salvarani C, Tani C, Zen M, Frigo AC, Tincani A, Doria A.

J Autoimmun. 2018 Jan;86:1-8. doi: 10.1016/j.jaut.2017.09.004. Epub 2017 Sep 19.

PMID:
28935492
20.

The Management of Systemic Lupus Erythematosus (SLE) Patients in Remission.

Zen M, Gatto M, Nalotto L, Larosa M, Iaccarino L, Doria A.

Isr Med Assoc J. 2017 Jul;19(7):454-458. Review. No abstract available.

21.

Performances of Kevlar and Polyethylene as radiation shielding on-board the International Space Station in high latitude radiation environment.

Narici L, Casolino M, Di Fino L, Larosa M, Picozza P, Rizzo A, Zaconte V.

Sci Rep. 2017 May 10;7(1):1644. doi: 10.1038/s41598-017-01707-2.

22.

Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.

Larosa MDP, Mackenzie R, Burne P, Garelli S, Barollo S, Masiero S, Rubin B, Chen S, Furmaniak J, Betterle C, Smith BR.

Clin Chem Lab Med. 2017 Jun 27;55(7):1003-1012. doi: 10.1515/cclm-2016-0615.

PMID:
28099118
23.

Evaluation of the stiffness characteristics of rapid palatal expander screws.

Lombardo L, Sacchi E, Larosa M, Mollica F, Mazzanti V, Spedicato GA, Siciliani G.

Prog Orthod. 2016 Dec;17(1):36. Epub 2016 Nov 28.

24.

Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus.

Iaccarino L, Bettio S, Reggia R, Zen M, Frassi M, Andreoli L, Gatto M, Piantoni S, Nalotto L, Franceschini F, Larosa M, Fredi M, Punzi L, Tincani A, Doria A.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):115-123. doi: 10.1002/acr.22971. Epub 2016 Nov 18.

25.

Advances in the diagnosis and classification of systemic lupus erythematosus.

Larosa M, Iaccarino L, Gatto M, Punzi L, Doria A.

Expert Rev Clin Immunol. 2016 Dec;12(12):1309-1320. Epub 2016 Jul 8. Review.

PMID:
27362864
26.

Generalized annular granuloma associated with crowned dens syndrome, which resolved with colchicine treatment.

Cozzani E, Basso D, Cimmino MA, Larosa M, Burlando M, Rongioletti F, Drago F, Parodi A.

Clin Exp Dermatol. 2016 Aug;41(6):640-2. doi: 10.1111/ced.12863. Epub 2016 Jun 23.

PMID:
27335228
27.

Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review.

Benvenuti F, Gatto M, Larosa M, Iaccarino L, Punzi L, Doria A.

Expert Opin Drug Saf. 2015;14(9):1373-85. doi: 10.1517/14740338.2015.1073259. Epub 2015 Jul 29. Review.

PMID:
26212119
28.

Bilateral Warthin tumor in psoriatic patients in therapy with multiple immunosuppressive therapy.

Burlando M, Cozzani E, Chinazzo C, Larosa M, Boggio M, Parodi A.

Int J Immunopathol Pharmacol. 2015 Mar;28(1):138-41. doi: 10.1177/0394632015572742.

PMID:
25816418
29.

Cranial reconstruction: 3D biomodel and custom-built implant created using additive manufacturing.

Jardini AL, Larosa MA, Maciel Filho R, Zavaglia CA, Bernardes LF, Lambert CS, Calderoni DR, Kharmandayan P.

J Craniomaxillofac Surg. 2014 Dec;42(8):1877-84. doi: 10.1016/j.jcms.2014.07.006. Epub 2014 Aug 6.

PMID:
25175080
30.

[History of laser in BPH therapy].

Grande M, Facchini F, Moretti M, Larosa M, Leone M, Ziglioli F, Pozzoli GL, Frattini A.

Urologia. 2014 Jan-Mar;81 Suppl 23:S38-42. doi: 10.5301/RU.2014.11985. Epub 2014 Mar 6. Review. Italian.

PMID:
24665033
31.

[Ejaculatory system cysts: a case report].

Moretti M, Facchini F, Grande M, Larosa M, Leone M, Ziglioli F, Carlinfante G, Pozzoli GL, Frattini A.

Urologia. 2014 Jan-Mar;81 Suppl 23:S32-7. doi: 10.5301/RU.2014.11999. Epub 2014 Mar 11. Italian.

PMID:
24665031
32.

Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial.

Assael BM, Pressler T, Bilton D, Fayon M, Fischer R, Chiron R, LaRosa M, Knoop C, McElvaney N, Lewis SA, Bresnik M, Montgomery AB, Oermann CM; AZLI Active Comparator Study Group.

J Cyst Fibros. 2013 Mar;12(2):130-40. doi: 10.1016/j.jcf.2012.07.006. Epub 2012 Sep 15.

33.

Heavy-ion anisotropy measured by ALTEA in the International Space Station.

Di Fino L, Casolino M, De Santis C, Larosa M, La Tessa C, Narici L, Picozza P, Zaconte V.

Radiat Res. 2011 Sep;176(3):397-406. Epub 2011 May 11.

PMID:
21561339
34.

Prevalence and epidemiology of microbial pathogens causing bloodstream infections: results of the OASIS multicenter study.

Luzzaro F, Ortisi G, Larosa M, Drago M, Brigante G, Gesu G.

Diagn Microbiol Infect Dis. 2011 Apr;69(4):363-9. doi: 10.1016/j.diagmicrobio.2010.10.016.

PMID:
21396530
35.

Comparative evaluation of synergy of combinations of beta-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae.

Drago L, Nicola L, Rodighiero V, Larosa M, Mattina R, De Vecchi E.

J Antimicrob Chemother. 2011 Apr;66(4):845-9. doi: 10.1093/jac/dkr016. Epub 2011 Feb 3.

PMID:
21393187
36.

[Endometriosis: aetiopathogenetic basis].

Larosa M, Facchini F, Pozzoli G, Leone M, Grande M, Monica B.

Urologia. 2010 Oct-Dec;77 Suppl 17:1-11. Review. Italian.

PMID:
21308668
37.

[A rare case of female bladder spontaneous rupture].

Facchini F, Pozzoli G, Larosa M, Leone M, Grande M, Monica B.

Urologia. 2009 Apr-Jun;76(2):156-60. Italian. No abstract available.

PMID:
21086322
38.

Specific immunotherapy for allergic rhinitis in Italy: the doctors points of view.

Larosa M, Ciprandi G, Tesi CF, Cadario G, Fiocchi A, Frati F, Romano A.

Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):251-154.

PMID:
19309575
39.

Specific immunotherapy for allergic rhinitis in Italy: the patients points of view.

Larosa M, Ciprandi G, Tesi CF, Cadario G, Fiocchi A, Frati F, Romano A.

Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):247-50.

PMID:
19309574
40.

Low grade epithelial stromal tumour of the seminal vesicle.

Monica B, Larosa M, Facchini F, Pozzoli G, Franceschetti I, Piscioli I.

World J Surg Oncol. 2008 Sep 23;6:101. doi: 10.1186/1477-7819-6-101.

41.

Doctors' and patients' educational levels affect immunotherapy prescription.

Ciprandi G, Larosa M, Tesi CF, Cadario G, Fiocchi A, Romano A, Frati F.

Int J Immunopathol Pharmacol. 2008 Apr-Jun;21(2):477-9.

PMID:
18547497
42.
43.

In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.

De Vecchi E, Nicola L, Larosa M, Drago L.

BMC Microbiol. 2008 Jan 29;8:23. doi: 10.1186/1471-2180-8-23.

44.

An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.

Segatore B, Perilli M, Larosa M, Setacci D, Celenza G, Amicosante G.

Int J Antimicrob Agents. 2007 Oct;30(4):374-6. Epub 2007 Jul 30. No abstract available.

PMID:
17659863
45.
46.

Management of CAP using a validated risk score.

Richeldi L, De Guglielmo M, Fabbri LM, Giovanardi D, Marchetti F, Larosa M, Solfrini V, Altini M.

Thorax. 2005 Feb;60(2):172-3. No abstract available.

47.

Prevalence and patterns of antibiotic prescribing in Italian hospitals.

Porretta A, Giuliani L, Vegni FE, Larosa M, Privitera G; INF-NOS Study Group.

Infection. 2003 Dec;31 Suppl 2:16-21.

PMID:
15018468
48.

Prevalence of nosocomial infections in 15 Italian hospitals: first point prevalance study for the INF-NOS project.

Nicastri E, Petrosillo N, Martini L, Larosa M, Gesu GP, Ippolito G; INF-NOS Study Group.

Infection. 2003 Dec;31 Suppl 2:10-5.

PMID:
15018467
49.

Time-kill curves as a tool for targeting ceftazidime serum concentration during continuous infusion.

Piccoli L, Larosa M, Marchetti F.

J Antimicrob Chemother. 2003 Dec;52(6):1047-8. Epub 2003 Oct 29. No abstract available.

PMID:
14585860
50.

Prevalence of interleukin 1 periodontal genotype in a Hispanic dental population.

Caffesse RG, De LaRosa MR, De LaRosa MG, Mota LF.

Quintessence Int. 2002 Mar;33(3):190-4.

PMID:
11921766

Supplemental Content

Loading ...
Support Center